KRM Ayurveda Ltd.
NNSE:KRMAYURVED238.80
INR
+5.75
(+2.47%)
ISIN
INE1MTV01019
Return %
Stock
S&P 500
1Y
- -
13.14
3Y
- -
80.78
5Y
- -
67.74
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Puneet Dhawan
- Full Time Employees
- 377
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- New Delhi India
- IPO Date
- Jan 29, 2026
- Website
- krmayurvedaindia.com
- Similar Companies
- Business
- KRM Ayurveda Limited is an India-based integrated healthcare and wellness company that specializes in traditional Ayurvedic clinical treatments, telemedicine services, and the manufacturing of herbal formulations. Founded in 2019 and headquartered in New Delhi, India, the company operates an integrated healthcare model combining physical multi-specialty clinical infrastructure with digital consultation channels and in-house pharmaceutical manufacturing. KRM Ayurveda operates through two core business segments: Clinical Healthcare Services and Ayurvedic Product Manufacturing. Its Clinical Healthcare Services division offers inpatient and outpatient medical care, classical Panchakarma therapies, dietary counseling, and specialized chronic ailment management across a network of hospitals and clinics in India, with primary therapeutic focus on nephrology and chronic kidney disease, liver disorders, diabetes, arthritis and musculoskeletal ailments, hypertension, and dermatological conditions; and global telemedicine operations providing remote video consultations, patient monitoring, and digital prescription fulfillment for domestic and international clientele. Its Ayurvedic Product Manufacturing segment develops, manufactures, and distributes over 300 Good Manufacturing Practice (GMP) certified and ISO 9001:2015 compliant classical and proprietary herbal products formulated at its manufacturing facility in Kundli, Haryana, marketed under the Karma Ayurveda brand; including herbal capsules, tablets, syrups, churnas (powders), tailas (therapeutic oils), kwaths (decoctions), topical ointments, and wellness supplements for renal support, metabolic regulation, digestive care, and immune health. In recent developments, the company converted from a private entity to a public limited company and changed its name from KRM Ayurveda Private Limited to KRM Ayurveda Limited in December 2024. In January 2026, the company completed its initial public offering (IPO) and listed its equity shares on the National Stock Exchange of India SME platform (NSE Emerge) under the ticker KRMAYURVED, utilizing the issue proceeds to establish advanced telemedicine operational facilities, expand healthcare IT and software infrastructure, hire specialized clinical personnel, and support working capital requirements. Over the past two years, KRM Ayurveda has executed a strategic shift from a pure-play herbal formulation manufacturer to an integrated clinical healthcare provider, expanding its footprint of physical healthcare facilities across India, including the establishment of MSS Hospital in Pitampura, New Delhi, while scaling its teleconsultation reach across overseas markets.